CPT-11 combined chemotherapy for metastatic gastric cancer |
| |
| Authors: | Narahara Hiroyuki Sugimoto Naotoshi Iishi Hiroyasu Tatsuta Masaharu |
| |
| Affiliation: | Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan. |
| |
| Abstract: | The effectiveness of chemotherapy for metastatic gastric cancer has been already revealed. But a standard chemotherapy has not been established yet. New agents such as TS-1, CPT-11 and taxanes are improving the response rates and also the survivals for gastric cancer. Including these new drugs, several randomized phase III trials are ongoing in Japan. In the near future, the candidate for standard resume will be sent abroad. In this article, we described the current state of CPT-11 combined chemotherapy for gastric cancer. Among various CPT-11- combined chemotherapy, CPT-11 + TS-1 is the most effective and less toxic treatment. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
